Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

9.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.9K
Cancer Survival Analysis01:21

Cancer Survival Analysis

486
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
486
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.0K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.9K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.9K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

560
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
560
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

214
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
214

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Non-Cancer Pain to Cancer Survivorship: Applying Opioid Deprescribing Lessons across the Divide.

Clinical pharmacology and therapeutics·2026
Same author

Treatment of Huntington's disease with a pan-HTT-targeting CRISPR nuclease.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Treatment of Huntington's disease with a pan-HTT-targeting CRISPR nuclease.

bioRxiv : the preprint server for biology·2026
Same author

Care Alert Program in Chronic Emergency Department Using Patients: Expanded Study.

HCA healthcare journal of medicine·2025
Same author

Clinical Outcomes of Perioperative Immunotherapy in Resectable Non-Small Cell Lung Cancer.

JAMA network open·2025
Same author

Bench to Budget: Integrated Evidence Generation for Medications.

Clinical pharmacology and therapeutics·2025

Related Experiment Video

Updated: Oct 31, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.5K

Emulating Control Arms for Cancer Clinical Trials Using External Cohorts Created From Electronic Health

Katherine Tan1, Jonathan Bryan1, Brian Segal1

  • 1Flatiron Health, Inc., New York, New York, USA.

Clinical Pharmacology and Therapeutics
|July 1, 2021
PubMed
Summary
This summary is machine-generated.

Electronic health record (EHR)-derived real-world data (RWD) can emulate oncology clinical trial control arms. While progression-free survival emulation was strong, overall survival showed more variability, highlighting the need for careful analytic approaches.

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.5K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.3K

Related Experiment Videos

Last Updated: Oct 31, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.5K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.5K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.3K

Area of Science:

  • Oncology
  • Real-world data analytics
  • Clinical trial methodology

Background:

  • Electronic health records (EHR) provide real-world data (RWD) valuable for research.
  • External comparator cohorts from RWD can supplement oncology clinical trials.
  • Assessing the feasibility of emulating trial control arms using RWD is crucial for trial design.

Purpose of the Study:

  • To evaluate the ability of EHR-derived RWD patient cohorts to emulate control arms of oncology clinical trials.
  • To assess the impact of analytical decisions on the accuracy of RWD cohort emulation.
  • To compare emulation performance for progression-free survival (PFS) and overall survival (OS) across multiple tumor types.

Main Methods:

  • Digitized Kaplan-Meier curves from 15 oncology trials supporting drug approvals (2016-2018).
  • Constructed RWD cohorts from a de-identified nationwide EHR database, aligning eligibility criteria and weighting to trial baseline characteristics.
  • Compared trial data and RWD cohorts using Kaplan-Meier and Cox regression models, including multitumor random effects models for hazard ratios (HRs).

Main Results:

  • Progression-free survival (PFS) emulation showed strong similarity between RWD cohorts and trial data (pooled HR=0.84, median correlation=0.91).
  • Overall survival (OS) emulation was less consistent, with greater variability in hazard ratios (pooled HR=0.76, median correlation=0.85).
  • OS hazard ratios in RWD cohorts trended towards worse outcomes, and a post hoc case study revealed significant impact of analytic choices on OS emulation.

Conclusions:

  • EHR-derived RWD can successfully emulate oncology clinical trial control arms, particularly for PFS.
  • Variability exists in OS emulation, influenced by specific analytical decisions.
  • Greater transparency into clinical trial cohort characteristics can refine RWD emulation strategies.